Research Consent for a Clinical Study: What to Ask First

By the Regenerative Evidence Guide Team

Research consent is the process of learning what a clinical study involves — its purpose, risks, benefits, and alternatives — before you agree to take part. If you’ve been handed a consent form for a regenerative medicine study, that form is a record of a conversation, not the decision itself.

This guide explains how the research consent process works under federal rules, what a consent form is required to tell you, and the specific questions worth asking before you sign anything. It does not evaluate any specific study, product, or clinic, and it isn’t a substitute for reading your own consent document or talking with the research team and, separately, your own doctor.

What Red Flags Should Make You Pause Before Signing a Consent Form?

A few situations are worth pausing on immediately, before you get further into a study’s consent process. If any of these apply, slow down and ask more questions before you sign anything:

If you’re told you must sign today or lose your spot in the study, then ask whether a short delay is truly impossible — federal guidance treats consent as a process you’re given time to think over, not a same-visit requirement.
If no one can tell you who to contact with questions later, or if something goes wrong, then the consent process is missing a required element and you should ask for that contact information before proceeding.
If the form is handed to you with no one offering to walk through it out loud, then ask for that conversation directly — a signed form alone is not considered adequate consent.
If you’re never told this is research, or the word “experimental” never comes up, then ask directly whether what’s being offered is standard care or part of a study.

If you ever have a medical emergency, that’s a call to local emergency services, not a research question.

What Are the Stages of the Research Consent Process?

Research consent for a clinical study is a sequence with several stages, not a single event. Understanding each stage helps you notice when one has been skipped:

Before you see any document. A member of the research team should explain, out loud, what the study is testing and why they think you might be a fit.
The consent discussion itself. Federal guidance describes this as “an active process of sharing information between the investigator and the prospective subject” — a conversation, not a form left on a counter. It can happen face-to-face, by phone, or by video.
The written consent document. This records what was discussed. Federal guidance is direct on this point: “even if a signed consent form is required, it alone does not constitute an adequate consent process.” The document is documentation of a conversation, not a replacement for one.
After you sign. Consent to participate in research isn’t frozen in time. If researchers learn something new during the study that could affect your willingness to continue, they’re expected to tell you and, in some cases, ask you to re-consent to keep participating.

A study team that skips stage one or two and hands you only stage three — a consent form, with no conversation attached — is skipping a required part of the process, not offering you a shortcut.

What Is a Research Consent Form Required to Tell You?

Research involving people is governed by a federal regulation known as 45 CFR 46, often called the “Common Rule.” It sets out specific elements that must be part of informed consent for any clinical study. In plain terms, your consent form and the conversation around it should tell you:

That this is research, what it’s testing, how long it’s expected to take, and which parts are experimental.
Any reasonably foreseeable risks or discomforts of taking part in the study.
Any benefits you or others might reasonably expect — described honestly, not designed to deliver.
What alternatives exist, including procedures or treatments outside the study that might help you, and the option of not participating at all.
How your information will be kept confidential, and the limits of that confidentiality.
If the research carries more than minimal risk: whether compensation or medical treatment is available if you’re injured during the study.
Who to contact with questions about the research, about your rights as a research participant, or in the event of a research-related injury.
A clear statement that participation is voluntary and that you can stop at any time without penalty or losing benefits you’re otherwise entitled to.

Depending on the study, the IRB (defined below) may also require the consent form to cover: unknown risks that aren’t yet foreseeable, circumstances under which the researcher could end your participation, any added costs from taking part in the study, what happens if you withdraw partway through, significant new findings discovered during the research, and roughly how many people are enrolled.

A quick definition: what is an IRB?

An Institutional Review Board (IRB) is a committee, independent of the research team, that reviews a clinical study before it starts to check that risks are minimized, confidentiality is protected, and consent procedures are fair — especially for anyone in a more vulnerable position. Federal guidance requires IRBs to ensure consent is obtained before you’re involved in the study, not after, and that the consent process minimizes any pressure or undue influence to participate. Reviewing a study’s public registry record before your consent conversation can help you arrive with informed questions about the study’s design and oversight.

What Questions Should You Ask Before Signing a Clinical Study Consent Form?

These questions map to what a consent form is legally required to cover. Bringing them into the consent conversation, rather than waiting to read them in a document, is one way to make sure the discussion is as thorough as the paperwork.

About the study itself

What exactly are you testing, and how does what I’d receive differ from an already-approved treatment?
What part of this clinical study is considered experimental?
Roughly how many people are enrolled, and is there a control or comparison group?

About risks and benefits

What are the known risks and discomforts of this study, and how likely is each one?
What benefit is realistically expected — to me, or only to future patients?
If I’m injured because of the study, is treatment or compensation available, and how would that work?

About alternatives

What would I do instead if I didn’t join this study — including doing nothing?
Are there other treatments, approved or investigational, that might address the same problem? A broader set of questions for evaluating any regenerative medicine option, inside or outside a study, is in our guide on questions to bring to a procedure conversation.

About voluntary participation

Can I leave the study at any point, for any reason, without losing access to care I’d otherwise get?
Are there costs to me if I withdraw from the study partway through?
Under what circumstances could the researchers end my participation without my choosing to leave?

About contacts and oversight

Who do I call with questions about the study itself?
Who do I call about my rights as a research participant, separate from the study team?
Which IRB approved this study, and can I see that approval?

About your own capacity to decide

Am I being asked to give consent for myself, or is someone else’s permission also required?
If my condition changes during the study, will I be asked to reconsider or re-sign consent?

What Should Be on Your Pre-Signing Checklist?

Bring this checklist to the consent conversation for your clinical study and check off each item before you sign anything:

I understand this is research, and I know which parts are experimental.
I’ve heard the risks and discomforts explained in plain language, not just read them.
I know what benefit is realistically expected, and I understand it isn’t designed to deliver.
I know what my alternatives are, including not participating in the study at all.
I’ve been told, clearly, that participation is voluntary and I can stop at any time without penalty.
I have a name and phone number for research questions, and a separate one for questions about my rights as a participant.
I know what happens — medically and financially — if I’m injured as a result of the study.
I’ve had enough time to read the form and ask questions, without feeling rushed.
I know I can ask for a copy of the signed consent form to keep for my own records.

Frequently Asked Questions About Research Consent

Can I withdraw from a clinical study after I’ve already signed consent?

Yes. Federal guidance requires that consent include a statement that you can discontinue participation at any time without penalty or loss of benefits you’re otherwise entitled to. Ask ahead of time what the process for withdrawing looks like and whether any follow-up steps are recommended for your safety.

Do I have to pay to be in a clinical study?

It depends on the study, and this is something your consent form should address directly. Consent documentation may be required to disclose any additional costs from participating, so this is a fair question to ask the research team before you sign anything.

What happens if I’m injured during a research study?

For research that carries more than minimal risk, consent must address whether compensation or medical treatment is available if you’re injured. Ask specifically what that would look like for your situation, and get the answer before you sign, not after.

Can someone else sign consent on my behalf?

Generally, only you can consent for yourself unless you lack the capacity to do so, in which case a legally authorized representative may be able to consent for you depending on the study and applicable rules. If your capacity to decide changes during the study, your own consent is required going forward once you’re able to give it.

Is a verbal explanation required, or is the written form enough?

A written form alone is not considered adequate consent under federal guidance. Consent is meant to be an active exchange of information between you and the research team, which can happen face-to-face, by phone, or by video, with the written document serving as a record of that conversation.

What This Guide Doesn’t Cover

This article explains the general research consent process required under federal rules for clinical studies. It doesn’t tell you whether a specific study, product, or clinic is right for you, and it isn’t a review of any particular consent form. It also doesn’t cover every situation — consent rules for research involving children, prisoners, or people who can’t consent for themselves involve additional protections not detailed here.

For a broader orientation to evaluating regenerative medicine claims generally, see our Start Here guide; for how we source and verify claims across this site, see How We Research. If you’re evaluating a specific study, the questions above are a starting point for a conversation with the research team and, separately, with your own doctor.

Sources

U.S. Department of Health and Human Services, Office for Human Research Protections — Informed Consent FAQs, guidance on the informed consent requirements of 45 CFR 46.
U.S. Department of Health and Human Services, Office for Human Research Protections — 45 CFR 46 FAQs, background on the federal regulation governing human subjects research.
ClinicalTrials.gov, a registry of clinical studies maintained by the U.S. National Library of Medicine — Learn About Studies, for readers who want to look up how a specific study is registered.

By Regenerative Evidence Guide Editorial Team. Last updated September 8, 2026. This article is for general education and does not replace a conversation with a research team’s staff, an Institutional Review Board, or your own doctor. Regenerative Evidence Guide is an independent publication and is not affiliated with any research institution, IRB, academy, clinic, or training program.